Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Placebo-Controlled Phase 2 Study of Emricasan in Acute-on-Chronic Liver Failure
2012-004245-33Phase 2Completed
- Sponsor
- Conatus Pharmaceuticals Inc.
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of emricasan in acute-on-chronic liver failure (ACLF), sponsored by Conatus Pharmaceuticals Inc.. Started May 2013; status: completed.
02
Drugs
emricasan
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on 2012-004245-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004245-33.